These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9710944)

  • 1. Kinetic analysis of prostatic volume and prostate specific antigen (PSA) in patients with advanced prostatic cancer treated by castration.
    Okihara K; Watanabe H; Saitoh M; Kojima M
    Tohoku J Exp Med; 1998 May; 185(1):37-44. PubMed ID: 9710944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of focal hypoechoic lesion in the prostate treated by castration.
    Okihara K; Watanabe M; Saitoh M; Ohe H; Watanabe H
    Prostate; 1994 May; 24(5):252-6. PubMed ID: 8170838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer.
    Naya Y; Fritsche HA; Bhadkamkar VA; Mikolajczyk SD; Rittenhouse HG; Babaian RJ
    Urology; 2004 Mar; 63(3):492-8. PubMed ID: 15028444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
    Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
    Tanaka N; Fujimoto K; Yoshikawa M; Tanaka M; Hirao Y; Kondo H; Saito I
    Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy.
    Lankford SP; Pollack A; Zagars GK
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):327-33. PubMed ID: 9226319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate.
    Feneley MR; Webb JA; McLean A; Kirby RS
    Br J Urol; 1995 Jan; 75(1):14-20. PubMed ID: 7531587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic study of tumor blood flow in prostatic cancer using power Doppler imaging.
    Okihara K; Watanabe H; Kojima M
    Ultrasound Med Biol; 1999 Jan; 25(1):89-94. PubMed ID: 10048805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating prostatic-specific antigen in benign hypertrophy and localized prostate cancer: can PSA be considered a screening examination for localized cancer?].
    Perrin P; Francois O; Maquet JH; Bringeon G; Duteil P; Devonec M
    Prog Urol; 1991 Jun; 1(3):419-31. PubMed ID: 1726943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels.
    Tanaka N; Fujimoto K; Chihara Y; Torimoto M; Hirao Y; Konishi N; Saito I
    Prostate Cancer Prostatic Dis; 2007; 10(3):274-8. PubMed ID: 17339878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictability of Gleason score and reduction time (tau) of prostatic volume after castration for the prognosis of prostatic cancer].
    Hongo F; Nakanouchi T; Nakamura J; Azuma Y; Iida A; Inoue W; Okihara K; Watanabe M; Saitoh M; Watanabe H; Konishi E; Ashihara T
    Nihon Hinyokika Gakkai Zasshi; 1998 Nov; 89(11):871-5. PubMed ID: 9866376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen dynamics predict risk of progression in advanced prostate cancer treated with bicalutamide plus castration.
    Altwein JE; Schmidt A
    Urol Int; 2002; 68(4):220-5. PubMed ID: 12053021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of prostatic planimetry using transrectal sonography in prostatic diseases.
    Watanabe H; Kojima M
    Semin Surg Oncol; 1997; 13(6):425-30. PubMed ID: 9358589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of seminal vesicles and prostate after medical castration: how long is the optimal duration of neoadjuvant treatment for prostate cancer before radiation?
    Furuya R; Hisasue S; Furuya S; Saitoh N; Ogura H; Takahashi S; Tsukamoto T
    Urology; 2008 Aug; 72(2):417-21. PubMed ID: 18267337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of specific prostatic antigen to prostatic volume ratio in the selection of patients for ultrasonography-guided biopsy of the prostate].
    Veneziano S; Pavlica P; Querzè R; Viglietta G; Trenta A
    Radiol Med; 1991 Jun; 81(6):857-60. PubMed ID: 1713333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of bilateral orchiectomy on volume changes of the prostate in men with advanced prostatic cancer--the predictive value.
    Zdrojowy R
    Int Urol Nephrol; 1992; 24(6):625-31. PubMed ID: 1289272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of reference values for total PSA, F/T and PSAD according to prostatic volume in japanese prostate cancer patients with slightly elevated serum PSA levels.
    Kuriyama M; Uno H; Watanabe H; Yamanaka H; Saito Y; Shida K
    Jpn J Clin Oncol; 1999 Dec; 29(12):617-22. PubMed ID: 10721944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonic volume monitoring in patient with prostate cancer treated by external beam radiation therapy.
    Saitoh M; Ramirez E; Babaian RJ
    Urology; 1994 Mar; 43(3):342-8. PubMed ID: 7510913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.